Zobrazeno 1 - 10
of 10
pro vyhledávání: '"A. J. Remmink"'
Autor:
René H.M. Verheijen, Theo J.M. Helmerhorst, A. J. Remmink, Chris J.L.M. Meijer, B. Mary E. von Blomberg-van der Flier, Antoine A.J.P. Robbesom, Hetty J. Bontkes, Marij J. Stukart, Paul Herbrink, Jan M. M. Walboomers, Tanja D. de Gruijl, Rik J. Scheper
Publikováno v:
International Journal of Cancer, 68(6), 731-8. Wiley-Liss Inc.
IgG reactivity against the immunodominant region aa6-35 of Human Papillomavirus (HPV) type-16 E7 was determined in a peptide-based ELISA in a cohort study of women with initial mild to moderate cervical dyskaryosis. On the basis of HPV DNA patterns,
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 156(21)
Insufficient weight loss after gastric band placement is generally linked to band-related complications or a persistently unhealthy diet.A 47-year-old woman with a history of gastric band placement presented with complaints of decreased mobility, dys
Autor:
Chris J. J. Mulder, Adriana J. Remmink, Abraham J. Wilhelm, John M.G. van Vugt, Adriaan A. van Bodegraven, Nanne K. H. de Boer, Ruurd M. van Elburg
Publikováno v:
De Boer, NK, van Elburg, R M, Wilhelm, A J, Remmink, A J, van Vugt, J M G, Mulder, C J J & van Bodegraven, A A 2005, ' 6-Thioguanine for Crohn's disease during pregnancy: thiopurine metabolite measurements in both mother and child ', Scandinavian Journal of Gastroenterology, vol. 40, no. 11, pp. 1374-1377 . https://doi.org/10.1080/00365520510024089
Scandinavian journal of gastroenterology, 40(11), 1374-1377. Informa Healthcare
Scandinavian Journal of Gastroenterology, 40(11), 1374-1377. Informa Healthcare
Scandinavian journal of gastroenterology, 40(11), 1374-1377. Informa Healthcare
Scandinavian Journal of Gastroenterology, 40(11), 1374-1377. Informa Healthcare
6-Thioguanine is used as an escape thiopurine for treating inflammatory bowel disease patients intolerant or refractory to azathioprine, 6-mercaptopurine or methotrexate. Case reports show conflicting data on the use of 6-thioguanine throughout pregn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aa99229fb2a12091416c7123f8ab3fa
https://research.vumc.nl/en/publications/1c0187ef-5251-497b-9bd9-ee4b7fa2eda6
https://research.vumc.nl/en/publications/1c0187ef-5251-497b-9bd9-ee4b7fa2eda6
Autor:
Hans C. van der Linden, M A E Nobbenhuis, Lawrence Rozendaal, A. J. Remmink, Jan M. M. Walboomers, Peter Kenemans, Theo J.M. Helmerhorst, Chris J.L.M. Meijer, Feja J. Voorhorst, Elle K.J. Risse
Publikováno v:
Lancet (London, England). 354(9172)
Summary Background A relation has been established between infection with high-risk types of human papillomavirus and development of cervical cancer. We investigated a role for testing for human papillomavirus as part of cervical-cancer screening. Me
Autor:
T D, de Gruijl, H J, Bontkes, J M, Walboomers, M J, Stukart, F S, Doekhie, A J, Remmink, T J, Helmerhorst, R H, Verheijen, M F, Duggan-Keen, P L, Stern, C J, Meijer, R J, Scheper
Publikováno v:
Cancer research. 58(8)
T-cell-mediated immune responses against oncogenic human papillomaviruses (HPVs) are believed to play a role in the prevention of cervical carcinogenesis. The in vitro production of interleukin 2 by CD4+ T helper (Th) cells in response to overlapping
Autor:
Hetty J. Bontkes, René H.M. Verheijen, M. J. Stukart, M. M. R. Chabaud, Rik J. Scheper, T. J. M. Helmerhorst, C. J. L. M. Meijer, T. D. De Gruijl, A. J. Remmink, J. M. M. Walboomers, John T. Schiller, B. S. Groot
Publikováno v:
Journal of the National Cancer Institute. 89(9)
Background Infection with cancer-linked human papillomavirus (HPV) types such as HPV type 16 (HPV16) is the most important risk factor in the development of cervical cancer. It has been shown that immunoglobulin G (IgG) antibody responses against HPV
Autor:
T D, de Gruijl, H J, Bontkes, J M, Walboomers, M J, Stukart, A A, Robbesom, B M, von Blomberg-van der Flier, P, Herbrink, A J, Remmink, R H, Verheijen, T J, Helmerhorst, C J, Meijer, R J, Scheper
Publikováno v:
International journal of cancer. 68(6)
IgG reactivity against the immunodominant region aa6-35 of Human Papillomavirus (HPV) type-16 E7 was determined in a peptide-based ELISA in a cohort study of women with initial mild to moderate cervical dyskaryosis. On the basis of HPV DNA patterns,
Autor:
A. J. Remmink, M. J. Stukart, Theo J.M. Helmerhorst, Hetty J. Bontkes, J. M. M. Walboomers, T. D. De Gruijl, C. J. L. M. Meijer, R.J. Scheper, René H.M. Verheijen
Publikováno v:
Journal of General Virology, 77 ( Pt 9), 2183-91. Society for General Microbiology
de Gruijl, T D, Bontkes, H J, Stukart, M J, Walboomers, J M, Remmink, A J, Verheijen, R H, Helmerhorst, T J, Meijer, C J & Scheper, R J 1996, ' T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection ', Journal of General Virology, vol. 77 ( Pt 9), pp. 2183-91 . https://doi.org/10.1099/0022-1317-77-9-2183
de Gruijl, T D, Bontkes, H J, Stukart, M J, Walboomers, J M, Remmink, A J, Verheijen, R H, Helmerhorst, T J, Meijer, C J & Scheper, R J 1996, ' T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection ', Journal of General Virology, vol. 77 ( Pt 9), pp. 2183-91 . https://doi.org/10.1099/0022-1317-77-9-2183
T cell proliferative responses against human papillomavirus type 16 (HPV-16) E7 protein were studied in relation to HPV status over time in 51 women originally diagnosed with abnormal cervical cytology and participating in a follow-up study. HPV-16-p
Autor:
Chris J.L.M. Meijer, Ellen K. J. Risse, Feja J. Voorhorst, Jan M. M. Walboomers, Lawrence Rozendaal, Theo J.M. Helmerhorst, A. J. Remmink, Peter Kenemans
Publikováno v:
International journal of cancer. 61(3)
To evaluate the clinical significance of HPV genotyping for the prediction of progressive cervical intraepithelial neoplasia (CIN) in women with cytomorphologically abnormal smears, a prospective, blind, non-intervention study was performed. A total
Autor:
Margaret F Duggan-Keen, T. D. De Gruijl, A. J. Remmink, Peter L. Stern, J. M. M. Walboomers, C. J. L. M. Meijer, M. J. Stukart, Theo J.M. Helmerhorst, R.J. Scheper, R.M.M. Verheijen, Hetty J. Bontkes
Publikováno v:
Immunology Letters. 56:223